These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22832750)

  • 1. Evaluating the effectiveness of an inactivated vaccine from Anaplasma marginale derived from tick cell culture.
    Lasmar PV; Carvalho AÚ; Facury Filho EJ; Bastos CV; Ribeiro MF
    Rev Bras Parasitol Vet; 2012; 21(2):112-7. PubMed ID: 22832750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection in the absence of exclusion between two Brazilian isolates of Anaplasma marginale in experimentally infected calves.
    Bastos CV; Passos LM; Facury-Filho EJ; Rabelo EM; Fuente Jde L; Ribeiro MF
    Vet J; 2010 Dec; 186(3):374-8. PubMed ID: 19837622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of cattle with Anaplasma marginale derived from tick cell culture and bovine erythrocytes followed by challenge-exposure with infected ticks.
    de la Fuente J; Kocan KM; Garcia-Garcia JC; Blouin EF; Claypool PL; Saliki JT
    Vet Microbiol; 2002 Oct; 89(2-3):239-251. PubMed ID: 12243900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protection between geographically distinct Anaplasma marginale isolates appears to be constrained by limited antibody responses.
    Kenneil R; Shkap V; Leibovich B; Zweygarth E; Pfister K; Ribeiro MF; Passos LM
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():97-104. PubMed ID: 24589108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of cattle with Anaplasma marginale derived from tick cell culture.
    Kocan KM; Halbur T; Blouin EF; Onet V; de la Fuente J; Garcia-Garcia JC; Saliki JT
    Vet Parasitol; 2001 Dec; 102(1-2):151-61. PubMed ID: 11705661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of bovines using a DNA vaccine (pcDNA3.1/MSP1b) prepared from the Jaboticabal strain of Anaplasma marginale.
    de Andrade GM; Machado RZ; Vidotto MC; Vidotto O
    Ann N Y Acad Sci; 2004 Oct; 1026():257-66. PubMed ID: 15604503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response and biochemistry of calves immunized with rMSP1a ( Anaplasma marginale) using carbon nanotubes as carrier molecules.
    Silvestre BT; Silveira JAGD; Facury-Filho EJ; Carvalho AÚ; Versiani AF; Estevam LGTM; Araújo MSS; Martins-Filho OA; Negrão-Corrêa DA; Ribeiro MFB
    Rev Bras Parasitol Vet; 2018; 27(2):191-202. PubMed ID: 29846449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a vertically transmitted strain from Anaplasma marginale (UFMG3): Molecular and phylogenetic characterization, and evaluation of virulence.
    Silvestre BT; Silveira JAG; Meneses RM; Facury-Filho EJ; Carvalho AU; Ribeiro MFB
    Ticks Tick Borne Dis; 2016 Feb; 7(1):80-84. PubMed ID: 26381444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplasma marginale field challenge: protection by an inactivated immunogen that shares partial sequence of msp1alpha variable region with the challenge strain.
    Vega LE; Rodríguez SD; Alarcón GJ; Flores RL; Ocampo RJ; Ortiz MA; de la Torre JF; Ramírez EE
    Vaccine; 2007 Jan; 25(3):519-25. PubMed ID: 17049686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplasma marginale inactivated vaccine: dose titration against a homologous challenge.
    Rodríguez SD; Garcîa Ortiz MA; Hernández Salgado G; Santos Cerda NA; Aboytes Torre R; Cantó Alarcón GJ
    Comp Immunol Microbiol Infect Dis; 2000 Oct; 23(4):239-52. PubMed ID: 11038126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens.
    Garcia-Garcia JC; de la Fuente J; Kocan KM; Blouin EF; Halbur T; Onet VC; Saliki JT
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):137-51. PubMed ID: 15010223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a subcutaneous ear implant to deliver an anaplasmosis vaccine to dairy steers.
    Curtis AK; Reif KE; Kleinhenz MD; Martin MS; Skinner B; Kelly SM; Jones DE; Schaut RG; Reppert EJ; Montgomery SR; Narasimhan B; Anantatat T; Jaberi-Douraki M; Coetzee JF
    J Anim Sci; 2020 Jun; 98(6):. PubMed ID: 31889177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tick cell line as a powerful tool to screen the antimicrobial susceptibility of the tick-borne pathogen Anaplasma marginale.
    Alonso BI; Ventura ES; Esteves E; Galletti MFBM; Dall'Agnol B; Martins JR; Klafke G; Reck J; Fogaça AC; Daffre S
    Exp Parasitol; 2020 Oct; 217():107958. PubMed ID: 32730769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of endothelial cells as an in vivo nidus of Anaplasma marginale infection in cattle.
    Wamsley HL; Alleman AR; Johnson CM; Barbet AF; Abbott JR
    Vet Microbiol; 2011 Dec; 153(3-4):264-73. PubMed ID: 21680112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and immunological characterization of three strains of Anaplasma marginale grown in cultured tick cells.
    Lis K; Fernández de Mera IG; Popara M; Cabezas-Cruz A; Ayllón N; Zweygarth E; Passos LM; Broniszewska M; Villar M; Kocan KM; Ribeiro MF; Pfister K; de la Fuente J
    Ticks Tick Borne Dis; 2015 Jun; 6(4):522-9. PubMed ID: 25943785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplasma marginale (Rickettsiales: Anaplasmataceae): recent advances in defining host-pathogen adaptations of a tick-borne rickettsia.
    Kocan KM; de la Fuente J; Blouin EF; Garcia-Garcia JC
    Parasitology; 2004; 129 Suppl():S285-300. PubMed ID: 15938516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental transmission of field Anaplasma marginale and the A. centrale vaccine strain by Hyalomma excavatum, Rhipicephalus sanguineus and Rhipicephalus (Boophilus) annulatus ticks.
    Shkap V; Kocan K; Molad T; Mazuz M; Leibovich B; Krigel Y; Michoytchenko A; Blouin E; de la Fuente J; Samish M; Mtshali M; Zweygarth E; Fleiderovich EL; Fish L
    Vet Microbiol; 2009 Mar; 134(3-4):254-60. PubMed ID: 18823724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to interrupt the development of Anaplasma marginale in its tick vector. The effect of bovine-derived antibodies.
    Kocan KM; Blouin EF; Palmer GH; Eriks IS; Edwards WL
    Ann N Y Acad Sci; 1996 Jul; 791():157-65. PubMed ID: 8784497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplasma marginale and Anaplasma phagocytophilum: Rickettsiales pathogens of veterinary and public health significance.
    Atif FA
    Parasitol Res; 2015 Nov; 114(11):3941-57. PubMed ID: 26346451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectivity and antigenicity of Anaplasma marginale from tick cell culture.
    Hidalgo RJ; Palmer GH; Jones EW; Brown JE; Ainsworth AJ
    Am J Vet Res; 1989 Dec; 50(12):2033-6. PubMed ID: 2610428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.